Retatrutide structure
Retatrutide
Retatrutide (LY-3437943) was discovered by the American pharmaceutical company Eli Lilly and Company. It is a triple glucagon hormone receptor agonist (GLP-1, GIP, and GCGR receptors) for obesity. The 2024 Lasker~DeBakey Clinical Medical Research Award has been given to Joel Habener and Svetlana Mojsov for their discovery of a new hormone GLP-1(7-37) and to Lotte Knudsen for her role in developing sustained acting versions of this hormone as a treatment for obesity.
Find 10 Related Holders
SICHUAN JISHENG BIOPHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
FUJIAN GENOHOPE BIOTECH LTD
United States
United States
API Registration Country
API Active
NANJING CELLNUO BIOPHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
HANGZHOU THINHEAL PHARMA-TECH CO LTD
United States
United States
API Registration Country
API Active
ZHEJIANG PEPTITES BIOTECH CO LTD
United States
United States
API Registration Country
API Active
GUIZHOU UTIDE BIOTECHNOLOGY CO LTD
United States
United States
API Registration Country
API Active
EL-PEPTIDO (SHANGHAI) BIOPHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
CHENGDU SHENGNUO BIOPHARM CO LTD
United States
United States
API Registration Country
API Active
HARBIN JIXIANGLONG BIOTECH CO LTD
United States
United States
API Registration Country
API Active
SINOPEP-ALLSINO BIOPHARMACEUTICAL CO LTD
United States
United States
API Registration Country
API Active
Recommended Suppliers of Retatrutide
-
Hangzhou Go Top Peptide Biotech Co.,Ltd.
CN1 YR
Contact Supplier -
Dalian Honglu Chemical Co., Ltd.
CN1 YR
Contact Supplier -
Jinan Million Pharmaceutical Co., Ltd
CN1 YR
Contact Supplier -
Runlian peptide supplier
CN1 YR
Contact Supplier -
Haikou Mingheng Biotechnology Co., Ltd.
CN1 YR
Contact Supplier